,,iii #aaith ,,congress #b;d ,session ,s4 ,,res4 #ijg ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,september #bd1 #bjbf,ms4 ,slotkin 7for herself and ,mrs4 ,britt7 submitted the following resolution2 which was referred to the ,committee on ,health1 ,education1 ,labor1 and ,pensions ,,resolution ,supporting the designation of ,september #bjbf as ,national ,ovarian ,cancer ,awareness ,month4 ,whereas ovarian cancer is the fifth-leading cause of cancer deaths of women in the ,united ,states and causes more deaths than any other gynecologic cancer2 ,whereas1 in the ,united ,states1 a woman's lifetime risk of being diagnosed with ovarian cancer is about #a in #ia2 ,whereas the ,american ,cancer ,society estimates #bj1jaj cases of ovarian cancer will be newly diagnosed in #bjbf1 and #ab1dej individuals will die from the disease nationwide2 ,whereas the #e-year survival rate for ovarian cancer is #ea4f percent1 and survival rates vary greatly depending on the stage of diagnosis2 ,whereas the #e-year survival rate for ovarian cancer exceeds #ij percent for individuals diagnosed in early stages2 ,whereas1 while the mammogram can detect breast cancer and the ,pap smear can detect cervical cancer1 there is no reliable early detection test for ovarian cancer2 ,whereas1 in ,june #bjjg1 the first national consensus statement on ovarian cancer symptoms was established to provide consistency in recognizing symptoms1 making them easier to identify and report2 ,whereas ,black women with ovarian cancer are more likely to receive late-stage diagnoses1 experience delayed or lower quality clinical care1 and face lower #e-year survival rates compared to non-,black women2 ,whereas disparities in care persist1 with ,black women experiencing lower survival rates than ,white women2 ,whereas women of color1 low-income women1 and women living in rural areas face systemic barriers to high-quality care and are less likely to receive treatment adhering to ,national ,comprehensive ,cancer ,network 7referred to in this preamble as the ,,nccn7 treatment guidelines2 ,whereas the proportion of ovarian cancer cases in women serving on active duty in the ,armed ,forces who are less than #de years of age is substantially greater than in the general population2 ,whereas the symptoms of ovarian cancer1 which include bloating1 pelvic or abdominal pain1 difficulty eating or feeling full quickly1 urinary symptoms1 and several other symptoms1 are often vague and are often easily misattributed to other diseases2 ,whereas improved public and clinical awareness of ovarian cancer symptoms can lead to earlier presentation1 faster diagnostic evaluation1 and expanded treatment options2 ,whereas the absence of an early detection test for ovarian cancer combined with its vague symptoms mean that approximately #hj percent of cases of ovarian cancer are detected at an advanced stage2 ,whereas gaps in collecting and reporting data on treatment and outcomes related to ovarian cancer risk1 especially for underserved communities and marginalized populations1 can impede the development of effective health policies2 ,whereas all women are at risk for ovarian cancer1 but approximately #bj percent of women who are diagnosed with ovarian cancer have a hereditary predisposition to ovarian cancer1 which places them at even higher risk2 ,whereas scientists and physicians have uncovered changes in the ,,brca genes that some women inherit from their parents1 which may make those women #cj times more likely to develop ovarian cancer2 ,whereas the family history of a woman has been found to play an important role in accurately assessing her risk of developing ovarian cancer1 and medical experts believe that family history should be taken into consideration during the annual well-woman visit of any woman2 ,whereas those women who have a family history of ovarian or breast cancer should consider genetic testing and counseling to determine whether their risk of developing a heritable cancer is elevated2 ,whereas women who know that they are at high risk of ovarian cancer may undertake prophylactic measures like a salpingo-oophorectomy to help reduce the risk of developing this disease2 ,whereas guidelines issued by the ,,nccn and the ,society of ,gynecologic ,oncology recommend that all individuals diagnosed with ovarian cancer receive genetic counseling and genetic testing regardless of their family history2 ,whereas studies continue to show that many individuals diagnosed with ovarian cancer do not receive recommended genetic counseling and testing2 ,whereas1 according to a consensus report by the ,national ,academy of ,medicine1 there remain surprising gaps in the fundamental knowledge about and understanding of ovarian cancer across all aspects of the disease2 ,whereas advances in precision medicine1 genetic testing1 targeted therapies1 and maintenance treatments have improved outcomes for many patients with ovarian cancer1 yet significant unmet needs remain1 particularly in early detection2 ,whereas ovarian cancer research remains underfunded relative to its mortality rate1 making increased ,federal investment critical to progress2 ,whereas ongoing investments in ovarian cancer research and education and awareness efforts are critical to closing these gaps and improving survivorship for women with ovarian cancer2 ,whereas1 each year during the month of ,september1 the ,ovarian ,cancer ,research ,alliance and community partner organizations hold a number of events to increase public awareness of ovarian cancer and its symptoms2 and ,whereas ,september #bjbf should be designated as ,national ,ovarian ,cancer ,awareness ,month to increase public awareness of ovarian cancer3 ,now1 therefore1 be it ,that the ,senate-- 7#a7 supports the designation of ,national ,ovarian ,cancer ,awareness ,month2 and 7#b7 supports the goals and ideals of ,national ,ovarian ,cancer ,awareness ,month4